1. Home
  2. CREG vs NEUP Comparison

CREG vs NEUP Comparison

Compare CREG & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CREG

Smart Powerr Corp.

HOLD

Current Price

$0.34

Market Cap

27.1M

Sector

Utilities

ML Signal

HOLD

NEUP

Neuphoria Therapeutics Inc.

N/A

Current Price

$4.41

Market Cap

23.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CREG
NEUP
Founded
N/A
1996
Country
China
United States
Employees
N/A
8
Industry
Power Generation
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
23.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CREG
NEUP
Price
$0.34
$4.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
4.7M
55.0K
Earning Date
03-27-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$867,431.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12953.89
N/A
52 Week Low
$0.20
$3.65
52 Week High
$2.66
$21.31

Technical Indicators

Market Signals
Indicator
CREG
NEUP
Relative Strength Index (RSI) 17.24 51.05
Support Level $0.20 $3.92
Resistance Level $1.47 $4.56
Average True Range (ATR) 0.26 0.25
MACD -0.08 -0.01
Stochastic Oscillator 5.21 38.03

Price Performance

Historical Comparison
CREG
NEUP

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: